Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics (Q38106640)

29 August 2017

Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics (English)

1 reference

29 August 2017

1 reference

A Paschos

1

1 reference

29 August 2017

R Pandya

series ordinal

2

1 reference

29 August 2017

W C M Duivenvoorden

series ordinal

3

1 reference

29 August 2017

J H Pinthus

series ordinal

4

1 reference

29 August 2017

14 May 2013

1 reference

Prostate Cancer and Prostatic Diseases

29 August 2017

1 reference

29 August 2017

16

1 reference

29 August 2017

3

1 reference

29 August 2017

217-225

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2013.13

29 August 2017

0 references

cites work

Free radicals in the physiological control of cell function

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Reconciling the chemistry and biology of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Nitrosative stress in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

15-lipoxygenase-1: a prooxidant enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Oxidative stress in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The role of oxidative stress in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Human prostate cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Role of oxygen radicals in DNA damage and cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The common biology of cancer and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Calcium, ATP, and ROS: a mitochondrial love-hate triangle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

What can surrogate tissues tell us about the oxidative stress status of the prostate? A hypothesis-generating in-vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Adiponectin inhibits oxidative stress in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The relationship between nutrition and prostate cancer: is more always better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Developmental estrogenization and prostatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Endocrine disruptors and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Thyroid hormone-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Phytoestrogens and breast cancer prevention: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Epidemiologic association between prostatitis and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Oxidative stress and DNA methylation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Oxidative lipidomics of gamma-irradiation-induced intestinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Redox regulation of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Protein sulfenic acids in redox signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Metal catalyzed oxidation of tyrosine residues by different oxidation systems of copper/hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

21 January 2018

Protein carbonylation.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Reactive oxygen species and regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Regulation of signal transduction through protein cysteine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Redox modulation of cellular metabolism through targeted degradation of signaling proteins by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Apoptosis and non-apoptotic deaths in cancer development and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Role of reactive oxygen species (ROS) in apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The interplay between autophagy and ROS in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Cysteine cathepsins: multifunctional enzymes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Expression of cathepsins B and S in the progression of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Homologous adaptation to oxidative stress induced by the photosensitized Pd-bacteriochlorophyll derivative (WST11) in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Contemporary role of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Clusterin and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Does vitamin E prevent or promote cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Bilirubin is an antioxidant of possible physiological importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Thiol chemistry and specificity in redox signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Lycopene and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Intake of carotenoids and retinol in relation to risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Selenoproteins and their impact on human health through diverse physiological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Molecular pathology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

21 January 2018

Mitochondria in cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Molecular biology of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Phytoestrogen intake and prostate cancer: a case-control study using a new database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.13

31 March 2020

Identifiers

DOI

10.1038/PCAN.2013.13

1 reference

29 August 2017

1 reference